For treatment of: diabetic polyneuropathy, treatment of peripheral blood supply disorders, impaired cognitive function.Actovegin nootropics
- For the treatment of internal organs: circulatory system, blood vessels
- Appointment: dementia, diabetic polyneuropathy, treatment of peripheral blood supply disorders, cognitive impairment
- Indications for use:
— as part of the complex therapy of metabolic and vascular disorders of the brain (various forms of cerebral circulatory failure, dementia, traumatic brain injury);
— peripheral (arterial and venous) vascular disorders and their consequences (angiopathy, trophic ulcers);
— diabetic polyneuropathy.
— hypersensitivity to the components of the drug or to similar drugs.
With caution, the drug should be prescribed for stage II-III heart failure, pulmonary edema, oliguria, anuria, hyperhydration, pregnancy and lactation.
Active substance: deproteinized hemoderivate of calves ' blood – 200 mg
Excipients: magnesium stearate – 2.0 mg, povidone K90 – 10.0 mg, talc – 3.0 mg, microcrystalline cellulose – 135.0 mg
- Manufacturer: Takeda